ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00254384
Brief Title: Neoadjuvant Chemotherapy With Docetaxel, Cisplatin Followed by Maintenance Therapy With the EGFR Inhibitor Erlotinib (Tarceva) Surgery for Non-Small Cell Lung Cancer (NSCLC) Following Definitive Surgical Resection

First Submitted : November 14, 2005
First Submitted that Met QC Criteria : November 14, 2005
First Posted : November 16, 2005 (Estimate)

Last Update Submitted that Met QC Criteria : September 13, 2018
Last Update Posted : September 14, 2018